Skip to main navigation Skip to search Skip to main content

Artificial Intelligence Applications in Diabetic Retinopathy: What We Have Now and What to Expect in the Future

  • Kangbuk Samsung Hospital

Research output: Contribution to journalReview articlepeer-review

Abstract

Diabetic retinopathy (DR) is a major complication of diabetes mellitus and is a leading cause of vision loss globally. A prompt and accurate diagnosis is crucial for ensuring favorable visual outcomes, highlighting the need for increased access to medical care. The recent remarkable advancements in artificial intelligence (AI) have raised high expectations for its role in disease diagnosis and prognosis prediction across various medical fields. In addition to achieving high precision comparable to that of ophthalmologists, AI-based diagnosis of DR has the potential to improve medical accessibility, especially through telemedicine. In this review paper, we aim to examine the current role of AI in the diagnosis of DR and explore future directions.

Original languageEnglish
Pages (from-to)416-424
Number of pages9
JournalEndocrinology and Metabolism
Volume39
Issue number3
DOIs
StatePublished - Jun 2024

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Artificial intelligence
  • Diabetes
  • Retinopathy
  • Telemedicine

Fingerprint

Dive into the research topics of 'Artificial Intelligence Applications in Diabetic Retinopathy: What We Have Now and What to Expect in the Future'. Together they form a unique fingerprint.

Cite this